BREAKING NEWS

US Supreme Court to hear 'pay-for-delay' drug case

By REUTERS

DECEMBER 7, 2012 23:13

The US Supreme Court on Friday agreed to decide whether brand-name drug companies may pay money to generic drug rivals to keep their lower-priced products off the market, a practice estimated to cost consumers and the government billions of dollars each year.

The arrangements, known as "pay-for-delay" or "reverse payments," have for more than a decade vexed antitrust enforcers including the Federal Trade Commission, which have been stung until recently by a series of court decisions allowing such practices.

In a typical case, a generic rival challenges the patent of a brand-name competitor, which then pays the rival a sum of money to drop its challenge. Defenders of the practice call it a legitimate means to resolve patent litigation.

Taiwan rattled by 6.1 magnitude quake, no immediate reports of damage

By REUTERS

04/26/2024 09:43 PM

IDF: Mt Hermon targeted by 30 launches, no known casualties

By JERUSALEM POST STAFF

04/26/2024 09:34 PM

Pentagon chief: Iran should question strategy after Israel attack failed

By REUTERS

04/26/2024 08:55 PM

Two expatriate workers killed by drone attack on Iraq's Khor Mor

By REUTERS

04/26/2024 08:52 PM